These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3727758)

  • 1. Influence of the particle size on the adjuvant effect of particulate polymeric adjuvants.
    Kreuter J; Berg U; Liehl E; Soliva M; Speiser PP
    Vaccine; 1986 Jun; 4(2):125-9. PubMed ID: 3727758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of hydrophobicity on the adjuvant effect of particulate polymeric adjuvants.
    Kreuter J; Liehl E; Berg U; Soliva M; Speiser PP
    Vaccine; 1988 Jun; 6(3):253-6. PubMed ID: 3420974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro studies of poly(methyl methacrylate) adjuvants.
    Kreuter J; Speiser PP
    J Pharm Sci; 1976 Nov; 65(11):1624-7. PubMed ID: 993993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold nanoparticles as an adjuvant: Influence of size, shape, and technique of combination with CpG on antibody production.
    Dykman LA; Staroverov SA; Fomin AS; Khanadeev VA; Khlebtsov BN; Bogatyrev VA
    Int Immunopharmacol; 2018 Jan; 54():163-168. PubMed ID: 29149704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of size on particulate vaccine adjuvants.
    Shah RR; O'Hagan DT; Amiji MM; Brito LA
    Nanomedicine (Lond); 2014 Dec; 9(17):2671-81. PubMed ID: 25529570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mode of action of immunological adjuvants: some physicochemical factors influencing the effectivity of polyacrylic adjuvants.
    Kreuter J; Haenzel I
    Infect Immun; 1978 Feb; 19(2):667-75. PubMed ID: 631894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles.
    Katare YK; Muthukumaran T; Panda AK
    Int J Pharm; 2005 Sep; 301(1-2):149-60. PubMed ID: 16023313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines.
    Jabbal-Gill I; Lin W; Jenkins P; Watts P; Jimenez M; Illum L; Davis SS; Wood JM; Major D; Minor PD; Li X; Lavelle EC; Coombes AG
    Vaccine; 1999 Sep; 18(3-4):238-50. PubMed ID: 10506648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods of effective conjugation of antigens to nanoparticles as non-inflammatory vaccine carriers.
    Xiang SD; Wilson K; Day S; Fuchsberger M; Plebanski M
    Methods; 2013 May; 60(3):232-41. PubMed ID: 23643867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cationic supported lipid bilayers for antigen presentation.
    Lincopan N; Espíndola NM; Vaz AJ; Carmona-Ribeiro AM
    Int J Pharm; 2007 Aug; 340(1-2):216-22. PubMed ID: 17452086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Microflow Digital Imaging Particle Analysis for Sub-Visible Particles Formulated with an Opaque Vaccine Adjuvant.
    Frahm GE; Pochopsky AW; Clarke TM; Johnston MJ
    PLoS One; 2016; 11(2):e0150229. PubMed ID: 26925777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of particle size and antigen binding on effectiveness of aluminum salt adjuvants in a model lysozyme vaccine.
    Clausi A; Cummiskey J; Merkley S; Carpenter JF; Braun LJ; Randolph TW
    J Pharm Sci; 2008 Dec; 97(12):5252-62. PubMed ID: 18398901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of immune stimulating adjuvants with poly(lactide-co-glycolide) microspheres enhances the immune response of vaccines.
    Salvador A; Igartua M; Hernández RM; Pedraz JL
    Vaccine; 2012 Jan; 30(3):589-96. PubMed ID: 22119926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adjuvant properties of polymer based on acrylic acid].
    Kozak MR; Oliĭnyk AV; Zaichenko OS; Vlizlo VV
    Ukr Biokhim Zh (1999); 2013; 85(3):69-73. PubMed ID: 23937050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-step immunization using a controlled release, biodegradable polymer with sustained adjuvant activity.
    Kohn J; Niemi SM; Albert EC; Murphy JC; Langer R; Fox JG
    J Immunol Methods; 1986 Dec; 95(1):31-8. PubMed ID: 3782824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adjuvant effect of particles-importance of genetic background and pre-sensitisation.
    Granum B; Gaarder PI; Eikeset A; Stensby BA; Løvik M
    Int Arch Allergy Immunol; 2000 Jul; 122(3):167-73. PubMed ID: 10899759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses.
    Oyewumi MO; Kumar A; Cui Z
    Expert Rev Vaccines; 2010 Sep; 9(9):1095-107. PubMed ID: 20822351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generic construction of single component particles that elicit humoural and cellular immune responses without the need for adjuvants.
    White PJ; Anastasopoulos F; Church JE; Kuo CY; Boyd BJ; Hickey PL; Tu LS; Burns P; Lew AM; Heath WR; Davey GM; Pouton CW
    Vaccine; 2008 Dec; 26(52):6824-31. PubMed ID: 18948160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soybean agglutinin coated PLA particles entrapping candidate vaccines induces enhanced primary and sustained secondary antibody response from single point immunization.
    Gupta RK; Goswami DG; Singh RR; Surolia A; Panda AK
    Eur J Pharm Sci; 2012 Feb; 45(3):282-95. PubMed ID: 22155747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the adjuvant effect of silver nanoparticles both in vitro and in vivo.
    Xu Y; Tang H; Liu JH; Wang H; Liu Y
    Toxicol Lett; 2013 May; 219(1):42-8. PubMed ID: 23454833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.